• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial Virus

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2025 Jul 24:ciaf405.
doi: 10.1093/cid/ciaf405. Online ahead of print. Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial Virus

Kevin C Ma[SUP] 1 [/SUP], Diya Surie[SUP] 1 [/SUP], Yuwei Zhu[SUP] 2 [/SUP], Carlos G Grijalva[SUP] 2 [/SUP], Paul W Blair[SUP] 3 [/SUP], Basmah Safdar[SUP] 4 [/SUP], Adit A Ginde[SUP] 5 [/SUP], Ithan D Peltan[SUP] 6 [/SUP], Samuel M Brown[SUP] 6 [/SUP], Manjusha Gaglani[SUP] 7 [/SUP], Shekhar Ghamande[SUP] 8 [/SUP], Cristie Columbus[SUP] 9 [/SUP], Nicholas M Mohr[SUP] 10 [/SUP], Kevin W Gibbs[SUP] 11 [/SUP], David N Hager[SUP] 12 [/SUP], Matthew E Prekker[SUP] 13 [/SUP], Michelle N Gong[SUP] 14 [/SUP], Amira Mohamed[SUP] 14 [/SUP], Nicholas J Johnson[SUP] 15 [/SUP], Jay S Steingrub[SUP] 16 [/SUP], Akram Khan[SUP] 17 [/SUP], Catherine L Hough[SUP] 18 [/SUP], Abhijit Duggal[SUP] 19 [/SUP], Alexandra June Gordon[SUP] 20 [/SUP], Nida Qadir[SUP] 21 [/SUP], Steven Y Chang[SUP] 21 [/SUP], Christopher Mallow[SUP] 22 [/SUP], Laurence W Busse[SUP] 23 [/SUP], Jennie H Kwon[SUP] 24 [/SUP], Matthew C Exline[SUP] 25 [/SUP], Ivana A Vaughn[SUP] 26 [/SUP], Mayur Ramesh[SUP] 27 [/SUP], Adam S Lauring[SUP] 28 [/SUP], Emily T Martin[SUP] 29 [/SUP], Aleda M Leis[SUP] 29 [/SUP], Jarrod M Mosier[SUP] 30 [/SUP], Estelle S Harris[SUP] 31 [/SUP], Adrienne Baughman[SUP] 32 [/SUP], Cassandra Johnson[SUP] 2 [/SUP], Jonathan D Casey[SUP] 33 [/SUP], Natasha Halasa[SUP] 34 [/SUP], James D Chappell[SUP] 34 [/SUP], Nathaniel Lewis[SUP] 35 [/SUP], Sascha Ellington[SUP] 35 [/SUP], Wesley H Self[SUP] 36 [/SUP], Fatimah S Dawood[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Adults hospitalized with acute respiratory infections, including respiratory syncytial virus (RSV), often have multiple underlying conditions. Few data are available on the combined effect of conditions on risk of severe outcomes from RSV disease.
Methods: We enrolled adults hospitalized with RSV at 26 hospitals in 20 US states admitted January 2022-July 2024. Seventeen underlying conditions were selected after excluding those with rare prevalence (≤1%) or high pairwise correlation (≥0.7). We applied Bayesian profile regression to identify profiles of conditions associated with increased risk of RSV severe outcomes, stratifying among adults aged 18-59 and ≥60 years.
Results: We analyzed data from 1111 adults hospitalized with RSV (median age [IQR] = 66 [53-75]). Among 397 adults aged 18-59 years, two profiles were identified: (1) minimal prevalence with fewer underlying conditions and a posterior median ICU admission risk of 21% (95% credible interval = [16‒25]); (2) cardiorenal/diabetes with frequent heart failure, chronic kidney disease, diabetes, and increased ICU admission risk (37% [27‒48]). Among 714 adults aged ≥60 years, four profiles were identified: (1) minimal prevalence (ICU admission risk = 22% [18‒26]), (2) cardiorenal/diabetes (27% [21‒34]), (3) hematologic malignancy and transplant receipt (12% [6‒21]), and (4) chronic pulmonary disease with home oxygen dependence (44% [25‒66]).
Conclusion: Distinct underlying condition profiles with varying risks of critical illness were observed among inpatients with RSV. These findings could support recognition of high-risk patients to inform RSV prevention strategies and suggest the role of multimorbidity in severe RSV disease risk warrants further attention.

Keywords: ICU admission; respiratory syncytial virus; risk factors; statistical clustering; underlying conditions.

 
Back
Top Bottom